Wouter Van’t Hof, Ph.D., Cord Blood Bank Director/Processing Facility Director

Wouter Van’t Hof has his Ph.D. in Cell Biology with over 15 years of biotech experience in translational research and development of adult stem cell therapies, including bone marrow stromal cells (MSC) and HPC, Cord Blood. He was the lead in acquiring FDA biologics license approval for HPC, Cord Blood product CLEVECORD™ and oversees CMC, Process Validation, Aseptic Processing, and GMP compliance. From 2002-2013, he was Director at Athersys (Cleveland, OH) and was responsible for technology transfer, product and process development, preclinical safety, regulatory discussion, clinical study design and management.